Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Articles
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (44)
  • 2025 (70)
  • 2024 (64)
  • 2023 (110)
  • 2022 (102)
  • 2021 (75)
  • 2020 (23)
  • 2019 (22)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4449)
  • Synthetic drugs (1227)
  • Guns/Weapons (1105)
  • OCDETF/Task Force (830)
  • Arrests/Convictions - Major (730)
  • Fake Pills (721)
  • Guilty Plea (589)
  • Seizures (Drugs/Property) (527)
  • Overdose (339)
  • Major Law Enforcement Operation (301)
  • Task Forces/Task Force Officers (274)
  • Take Back Day (268)
  • Pharmaceuticals/Pharmacists/Physicians (244)
  • Money Laundering (231)
  • Gangs (210)
  • Outreach/Drug Prevention (199)
  • Fentanyl Awareness (197)
  • One Pill Can Kill (128)
  • HIDTA (110)
  • Fentanyl Free America (89)
  • Press Conferences (74)
  • Counterfeit Pills (65)
  • Extraditions (57)
  • Prevention/Education - DEA websites GSAD, JTT etc (57)
  • Narcoterrorism (56)
  • Public and Media Affairs - also see Congressional Affairs (53)
  • Asset Forfeiture (31)
  • Dark Web- Internet Trafficking (31)
  • International/Foreign Operations (30)
  • Red Ribbon (28)
  • Campaigns (24)
  • Other (16)
  • Congressional Affairs (15)
  • Terrorism (15)
  • Cartel (11)
  • Critical Incident (10)
  • Intergovernmental Affairs (9)
  • Intelligence Division - Intelligence Products (6)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (398)
  • Diversion Division (279)

Drug Name

  • Oxycodone (87)
  • Fentanyl (73)
  • Opioids (66)
  • Hydromorphone (25)
  • Synthetic Opioids (23)
  • Methamphetamine (20)
  • Benzodiazepines (18)
  • Morphine (14)
  • Cocaine (12)
  • Amphetamines (11)
  • Heroin (8)
  • Marijuana (Cannabis) (5)
  • Methadone (5)
  • Steroids (4)
  • Ketamine (3)
  • GHB (2)
  • Psilocybin (2)
  • Ecstasy/MDMA (1)
  • LSD (1)
  • Marijuana Concentrates (1)

Field Division

  • Atlanta (24)
  • Caribbean (1)
  • Chicago (24)
  • Dallas (16)
  • Detroit (4)
  • El Paso (19)
  • Headquarters (28)
  • Houston (25)
  • Los Angeles (11)
  • Louisville (14)
  • Miami (25)
  • New England (53)
  • New Jersey (20)
  • New Orleans (12)
  • New York (54)
  • Omaha (12)
  • Philadelphia (1)
  • Phoenix (9)
  • Rocky Mountain (11)
  • San Diego (8)
  • San Francisco (17)
  • Seattle (34)
  • St. Louis (47)
  • Washington, DC (49)
Clear All Results
518 Results - Showing 481 to 490
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...
PRESS RELEASE

Omnicare agrees to pay over $15 Million to resolve allegations it improperly dispensed opioids at long-term care facilities

PORTLAND, Ore.—Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by, among other things, allowing opioids and other controlled substances to be...
PRESS RELEASE

Wisconsin physician agrees to pay penalties to resolve allegations of prescribing opioids illegally and violating False Claims Act

MILWAUKEE - DEA Assistant Special Agent in Charge Paul E. Maxwell and United States Attorney Matthew D. Krueger announced today that Dr. Mehran Heydarpour of Brookfield, Wisconsin, agreed to pay $175,000 to resolve allegations that he prescribed opioid pain medications in violation of the Controlled Substances Act and that he...
PRESS RELEASE

Three doctors indicted for conspiring to distribute oxycodone

ST. LOUIS – Eleven individuals were indicted today by a federal grand jury for conspiracy to distribute controlled medications, such as oxycodone, without a legitimate medical purpose, obtaining controlled medication by deceit and subterfuge, paying and receiving illegal kickbacks for referrals to lab for urine tests of the patients, and...
PRESS RELEASE

St. Louis County dentist sentenced to 18 months after issuing illegal prescriptions for opioid narcotic drugs

ST. LOUIS – Bradley A. Seyer, D.D.S., 53, of Florissant, Missouri, was sentenced today to 18 months of imprisonment and a $50,000 fine. Previously, on June 26, 2019, Dr. Seyer pleaded guilty to two felony charges of making false statements to Medicare and illegally issuing prescriptions for narcotic opioid drugs...
PRESS RELEASE

St. Louis County doctor pleads guilty to fraudulently obtaining opioid narcotic prescription drugs

ST. LOUIS – Angela K. Williams, M.D., 34, of Brentwood, Missouri, pleaded guilty today to one felony charge of fraudulently obtaining oxycodone, a narcotic opioid prescription drug. This case was investigated by the Drug Enforcement Administration St. Louis Division, the Florissant Police Department, the Town and Country Police Department, and...
PRESS RELEASE

Pain management doctor pleads guilty to conspiracy to distribute controlled substances and health care fraud

BUFFALO, N.Y. – U.S. Attorney James P. Kennedy, Jr. and U.S. Drug Enforcement Administration New York Division Special Agent in Charge Ray Donovan announced today that Dr. Eugene Gosy, 59, of Clarence, N.Y., pleaded guilty before Chief U.S. District Judge Frank P. Geraci, Jr. to conspiracy to distribute controlled substances...
PRESS RELEASE

Champaign man sentenced to 13 years in prison for trafficking

URBANA, Ill. – U.S. District Judge Michael M. Mihm today sentenced a Champaign, ll., man, Stephan Caamano, to 13 years in federal prison for trafficking at least 4.3 million counterfeit Xanax pills throughout the country and laundering the proceeds. Caamano has been ordered to pay more than $2.1 million he...
PRESS RELEASE

Federal grand jury adds two new charges resulting in death against Carrizo Springs doctor

SAN ANTONIO - In Del Rio, a federal grand jury added two new charges of distribution of a controlled substance resulting in death to an existing 20-count indictment returned in May against Dr. Alfonso Luevano, announced DEA Houston Division Special Agent in Charge Will Glaspy, U.S. Attorney John F. Bash...
PRESS RELEASE

Overprescribing opioids costs La Jolla doctor $125,000

SAN DIEGO – Dr. Roger A. Kasendorf, an osteopathic physician practicing in La Jolla, agreed to pay $125,000 to resolve allegations that he illegally prescribed opioids to his patients. The highly addictive and frequently abused opioids he prescribed included fentanyl, hydromorphone, oxymorphone, and oxycodone. In response to the Justice Department’s...

Pagination

  • First page «
  • Previous
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Current page 49
  • Page 50
  • Page 51
  • Page 52
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster